Ways to improve adherence to long-term injection therapy in multiple sclerosis using the example of pegylated interferon-β1a (sampeginterferon β-1a)

Patient adherence to therapy with multiple sclerosis disease-modifying treatments (MS DMTs) in many cases determine the effectiveness of therapy. The review discusses the reasons for low adherence to DMTs, ways to increase it. Among the most effective ways is to reduce the frequency of administratio...

Deskribapen osoa

Xehetasun bibliografikoak

Egile nagusia:	A. N. Boyko
Formatua:	Artigo
Hizkuntza:	Russo
Argitaratua:	IMA-PRESS LLC 2022-08-01
Saila:	Неврология, нейропсихиатрия, психосоматика
Gaiak:	multiple sclerosis treatment multiple sclerosis disease-modifying treatments adherence to therapy sampeginterferon
Sarrera elektronikoa:	https://nnp.ima-press.net/nnp/article/view/1851
Etiketak:	Etiketa erantsi Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!